Evaluation for NCI Surgery Branch Clinical Research Protocols

Part of paid clinical trials in Bethesda, Maryland.

Sponsor
National Cancer Institute (NCI)
Study ID
NCT00001823
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.

Key Dates

Start date
Jul 11, 1999
Status verified
Jun 2026

Study Design

Enrollment
7,000 participants (estimated)

Arms

  • Arm: A/Surgery Branch Protocol Candidates
    Patients suspected of having, or with biopsy proven, malignant disease being evaluated for or treated on NCI Surgery Branch protocols

Primary Outcome Measure

Number of individuals suitable for NCI Surgery Branch clinical research protocols [ Time Frame: 25 Years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
National Institutes of Health Clinical CenterBethesdaMaryland20892
For more information at the NIH Clinical Center contact National Cancer Institute Referral Office
888-624-1937

Find similar trials in Bethesda, MD

By condition
Bladder cancerColorectal cancerLung cancerMelanoma
By specialty
OncologyUrologyGI oncologyLung oncologyLung diseaseSkin cancerDermatology
By research site
National Institutes of Health Clinical Center· Bethesda, MD

Related Studies